Search For "interim trial data"
AstraZeneca booster dose works against Omicron, says Oxford lab study
Updated : 4 years, 3 months ago IST
London [UK], December 23 (ANI): The University of Oxford, in collaboration with AstraZeneca, has announced interim trial data from its Phase III trials that show its candidate coronavirus vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of
Read More